A Prospective Validation Study of Bioimpedance with Volume Displacement in Early-Stage Breast Cancer Patients at Risk for Lymphedema

Annals of Surgical Oncology

Volumn 22, Issue , 2015, Pages 370-375

  Barrio, Andrea V ^a,b   Eaton, Anne ^a   Frazier, Thomas G ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BRYN MAWR HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIOIMPEDANCE DEVICE; BREAST CANCER; CANCER PATIENT; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC EQUIPMENT; EARLY CANCER; EXTRACELLULAR FLUID; EXTRACELLULAR SPACE; FEMALE; FLUID SHIFT; FOLLOW UP; HUMAN; LYMPHEDEMA; MAJOR CLINICAL STUDY; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; VOLUME DISPLACEMENT; ADVERSE EFFECTS; BREAST NEOPLASMS; CANCER STAGING; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COMPLICATION; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; IMPEDANCE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROCEDURES; PROGNOSIS; TUMOR INVASION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COMBINED MODALITY THERAPY; DIELECTRIC SPECTROSCOPY; ELECTRIC IMPEDANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHEDEMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84952874769     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4683-0     Document Type: Article

References (14)

1. Tsai RJ, Dennis LK, Lynch CF, et al. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009;16(7):1959–72.
2. Dodds RL, Nielsen KA, Shirley AG, et al. Test-retest reliability of the commercial volumeter. Work. 2004;22(2):107–10.
3. Karges JR, Mark BE, Stikeleather SJ, et al. Concurrent validity of upper-extremity volume estimates: comparison of calculated volume derived from girth measurements and water displacement volume. Phys Ther. 2003;83(2):134–45.
4. Fu MR, Cleland CM, Guth AA, et al. L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity. Lymphology. 2013;46(2):85–96.
5. Smoot BJ, Wong JF, Dodd MJ. Comparison of diagnostic accuracy of clinical measures of breast cancer-related lymphedema: area under the curve. Arch Phys Med Rehabil. 2011;92(4):603–10.
6. Cornish BH, Chapman M, Hirst C, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology. 2001;34(1):2–11.
7. Blaney JM, McCollum G, Lorimer J, et al. Prospective surveillance of breast cancer-related lymphoedema in the first-year post-surgery: feasibility and comparison of screening measures. Support Care Cancer. 2015;23(6):1549–59.
8. Armer JM, Stewart BR. A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol. 2005;3(4):208–17.
9. Stout Gergich NL, Pfalzer LA, McGarvey C, et al. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112(12):2809–19.
10. Shih YC, Xu Y, Cormier JN, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27(12):2007–14.
11. Hayes SC, Speck RM, Reimet E, et al. Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial. Breast Cancer Res Treat. 2011;130(1):227–34.
12. Specht MC, Miller CL, Russell TA, et al. Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression? Breast Cancer Res Treat. 2013;140(3):485–94.
13. Dengel LT, Van Zee KJ, King TA, et al. Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Ann Surg Oncol. 2014;21(1):22–7.
14. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75.